Parallel Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
GCP
EAM
Parallel Advisors's EDIT Position: Q2 2026 in Review
Parallel Advisors held its Editas Medicine (EDIT) position steady in Q2 2026 at 60 shares worth $194. The position accounts for ﹤0.01% of the portfolio, ranked #3852.
Parallel Advisors first reported a position in EDIT in Q1 2019 and has held it in 25 quarters since. The position peaked at $14K in Q4 2020. 79 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- Parallel Advisors held 60 shares of Editas Medicine worth $194 as of Q2 2026.
- Parallel Advisors left its Editas Medicine share count unchanged in Q2 2026.
- Editas Medicine made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3852 holding.
- Parallel Advisors first reported a position in Editas Medicine in Q1 2019 and has held it in 25 quarters since.
- Parallel Advisors's Editas Medicine position peaked at $14K in Q4 2020.
- 79 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.